Dapagliflozin effectively reduces blood sugar and weight in type 1 diabetes: Study Medha Baranwal11 Nov 2020 11:15 AM ISTDelhi: A recent study evaluating dapagliflozin for the treatment of patients with type 1 diabetes (T1D) has yielded positive results. According to the...
Drug combo controls blood sugar, weight and BP in Diabetics: Study Dr. Kamal Kant Kohli3 Nov 2020 12:00 PM ISTPHILADELPHIA - Researchers at Thomas Jefferson University have found in a new multi-center double-blind, phase 3, randomized controlled trial that ...
Dapagliflozin Going Off Patent with a Slashed Price Hina Zahid3 Nov 2020 11:30 AM ISTDiabetes is well-known to adversely impact the heart, vascular system and renal system. The patients with type 2 diabetes mellitus (T2DM) are at...
Price war over Diabetes drug Dapagliflozin: AstraZeneca drags 12 drugmakers to Delhi court Farhat Nasim16 Oct 2020 5:30 PM ISTNew Delhi: Proclaiming a legal battle against 12 Indian drugmakers, AstraZeneca has moved Delhi high court against the dozen firms for eyeing to roll...
NPPA fixes retail price of 26 formulations; Details Farhat Nasim30 Sept 2020 3:51 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Dapagliflozin reduces Renal Risk in CKD, irrespective of Diabetes Status: NEJM Dr Satabdi Saha25 Sept 2020 8:58 PM ISTThe sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk for kidney disease progression and death in patients with chronic...
SGLT2 inhibitors improve survival and renal outcomes in heart failure: Lancet Medha Baranwal16 Sept 2020 7:50 AM ISTFrance: Treatment with empagliflozin and dapagliflozin reduces all-cause mortality and improves renal outcomes in patients with heart failure with...
Dapagliflozin reduces hyperkalaemia risk in heart failure with reduced EF: Study Dr Satabdi Saha11 Sept 2020 1:15 PM ISTPatients with heart failure and reduced ejection fraction (HFrEF) and taking a mineralocorticoid receptor antagonists (MRA) who were randomized to...
AstraZeneca diabetes drug dapagliflozin shows significant benefits in CKD patients Ruchika Sharma3 Sept 2020 3:33 PM ISTBangalore: AstraZeneca India has announced the full results from the clinical trials of it's latest diabetes drug, dapagliflozin, showing...
Dapagliflozin prolongs survival in CKD patients with or without Diabetes: DAPA-CKD Hina Zahid2 Sept 2020 4:45 AM ISTSophia Antipolis, France - Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalisation and...
AstraZeneca heart failure drug Dapagliflozin gets DCGI approval Ruchika Sharma6 July 2020 12:38 PM ISTThe company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication). The receipt of the...
SGLT2 inhibitor dapagliflozin when used for heart failure may prevent diabetes Dr. Kamal Kant Kohli16 Jun 2020 10:06 AM ISTChicago, Illinois- Analysis of large international DAPA-HF trial participants notes diabetes prevention benefit in patients with heart failure who...
